Type 1 diabetes is more prevalent in Finland than anywhere else in the world, affecting approximately 50,000 people. New ...

A recent study conducted in Finland shows that automated insulin delivery pumps significantly improved quality of life and reduced diabetes-related complications. The quality-adjusted life expectancy ...

Type 1 diabetes is more prevalent in Finland than anywhere else in the world, affecting approximately 50,000 people.

Detailed price information for Takeda Pharmaceutical Ltd ADR (TAK-N) from The Globe and Mail including charting and trades.

Skin rash from diabetes medical devices is common, under-recognized, and expected to increase as device use increases.

That silence around Type 1 diabetes is exactly what advocates and educators hope to change. In a move toward inclusivity and awareness, a new Barbie doll has been released, Barbie with Type 1 diabetes ...

Panelists discuss how the rapid adoption of subcutaneous (SubQ) oncology therapies creates challenges around clinical ...

Integrating a mix of IV and SubQ therapies into oncology infusion centers requires a flexible and integrated operational model. One effective strategy is cross-utilization of nursing staff ...

The North America Syringe Infusion Pumps Market is projected to grow from USD 645.1 million in 2024 to USD 1.04 billion by 2030, at a CAGR of 8.40%. Key drivers include an increase in chronic diseases ...

Tackling water pollution - new “gas infusion” technology that has already proven effective Tackling water pollution - new “gas infusion” technology that has already proven effective Earth ...

Discover the four key trends and innovations driving infusion therapy for chronic diseases as we head into 2025. Stay informed and up-to-date on the latest advancements in healthcare.